TREM2 and Alzheimer disease: Recent studies have demonstrated that the R47H variant of triggering receptor expressed on myeloid cells 2 (TREM2), a receptor expressed in microglia, significantly increases the risk of nonfamilial AD (Guerreiro et al., 2013; Jonsson et al., 2013).